Ambulatory Cancer Pain Management: A Feasibility Study
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary purpose of this study is to examine the feasibility of collecting pain and other symptom data in outpatient treatment centers across multiple institutions in the Texas Medical Center (TMC). We will also examine the prevalence and severity of cancer-related pain and begin to identify other commonly reported symptoms in outpatient settings. Factors that interfere with management of pain will also be examined. Additionally, the study will explore patient satisfaction with pain management and pain education in outpatient settings. The specific aims of this study include:
Primary Objective:
-Explore the feasibility of a collaborative effort by oncology nurses to collect pain and symptom data across multiple institutions that care for ambulatory cancer patients in the TMC.
Secondary Objectives:
- Describe the prevalence and severity of pain and other symptoms in persons with breast, colorectal, lung, or prostate cancer who are receiving chemotherapy in the outpatient setting.
- Describe factors that interfere with adequate pain management in these patients.
- Examine patient satisfaction with pain management and patient education about pain management.
| Condition | Intervention |
|---|---|
|
Breast Cancer Colorectal Cancer Lung Cancer Prostate Cancer |
Behavioral: Questionnaire |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Ambulatory Cancer Pain Management: A Feasibility Study |
- Pain and symptom data across multiple institutions [ Time Frame: Survey data collection taking 30 minutes, collecation accomplished at multiple sites over 3 years ] [ Designated as safety issue: No ]
| Enrollment: | 30 |
| Study Start Date: | July 2006 |
| Study Completion Date: | July 2009 |
| Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Cancer Pain Management
Patients receiving chemotherapy for breast, colon, lung, or prostate cancer.
|
Behavioral: Questionnaire
3 questionnaires that will take 20 minutes total to complete.
Other Name: Survey
|
Detailed Description:
You will be asked to complete 3 questionnaires that will take a total of about 20 minutes to complete. Your name or medical record number will not appear on the questionnaires. You will be assigned a study subject code number. The study chair will keep a file that links your name to the code.
The first questionnaire will ask for basic demographic information (such as gender, ethnicity, and education) and your current chemotherapy and pain medications. If you cannot remember the names of these medications, researchers will locate them in your M. D. Anderson medical record.
The second questionnaire asks you to rate your pain and a variety of symptoms (for example, fatigue and nausea).
The last questionnaire includes 3 sections. The first section asks about your beliefs about pain and its treatment. The second part asks for your opinion about your pain management and about the education you have received about pain management. On the last page, you will be asked to use a picture of the outline of a body to show the researchers where you have pain.
Once you have completed these questionnaires, you will be considered off-study.
This is an investigational study. Up to 125 patients will take part in this study. Up to 35 will be enrolled at M. D. Anderson.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients receiving chemotherapy for breast, colon, lung, or prostate cancer.
Inclusion Criteria:
- Diagnosis of breast, colorectal, lung, or prostate cancer (any histological type).
- Currently undergoing chemotherapy.
- Age 18 or older.
- Able to read, write, and speak English.
- Able to understand the purpose of this study.
- Must be a patient at one of the four participating institutions.
- Must be receiving the 2nd, 3rd, or 4th cycle of chemotherapy.
Exclusion Criteria:
- Receiving chemotherapy in preparation for a bone marrow or stem cell transplant
- Received a bone marrow or stem cell transplant
- Age 17 or younger
- Receiving weekly chemotherapy.
- Receiving hormonal therapy alone.
- Receiving radiation or chemoradiation.
Contacts and Locations| United States, Texas | |
| U.T.M.D. Anderson Cancer Center | |
| Houston, Texas, United States, 77030 | |
| Michael E. DeBakey Veterans Administration Medical Center | |
| Houston, Texas, United States, 77030 | |
| Methodist Hospital | |
| Houston, Texas, United States, 77030 | |
| Memorial Hermann Hospital | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | Anita Broxson, RN | M.D. Anderson Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00507351 History of Changes |
| Other Study ID Numbers: | 2005-0841 |
| Study First Received: | July 24, 2007 |
| Last Updated: | July 31, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by M.D. Anderson Cancer Center:
|
Breast Cancer Colorectal Cancer Lung Cancer Prostate Cancer |
Pain Management Questionnaire Survey |
Additional relevant MeSH terms:
|
Breast Neoplasms Colorectal Neoplasms Lung Neoplasms Prostatic Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Digestive System Diseases |
Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013